Cleared Special

K121905 - ALERE PBP2A TEST

K121905 is an FDA 510(k) clearance for ALERE PBP2A TEST, manufactured by Alere Scarborough, Inc.. The device is a Class 2 Microbiology device with product code MYI cleared through the Special 510(k) pathway after a 27-day FDA review.

K121905 · Alere Scarborough, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2012
Decision
27d
Days
Class 2
Risk

K121905 is an FDA 510(k) clearance for the ALERE PBP2A TEST. Classified as System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies (product code MYI), Class II - Special Controls.

Submitted by Alere Scarborough, Inc. (Scarborough, US). The FDA issued a Cleared decision on July 26, 2012 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1640 - the FDA microbiology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Alere Scarborough, Inc. devices

FDA 510(k) Submission Details - K121905

510(k) Number K121905 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 29, 2012
Decision Date July 26, 2012
Days to Decision 27 days
Submission Type Special
Review Panel Microbiology (MI)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
75d faster than avg
Panel avg: 102d · This submission: 27d
Pathway characteristics
Modification to existing cleared device.

MYI Device Classification - Class 2, Special Controls

Product Code MYI System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - MYI System, Test, Genotypic Detection, Resistant Markers, Staphylococcus Colonies

Devices cleared under the same product code (MYI) and FDA review panel - the closest regulatory comparables to K121905.
MECA XPRESSFISH
K140619 · Advandx, Inc. · Oct 2014
ALERE PBP2A SA/CONS CULTURE COLONY TEST
K133851 · Alere Scarborough, Inc. · Sep 2014
BINAXNOW PBP2A TEST, MODEL 890-000
K090301 · Binax, Inc. · Apr 2010
CLEARVIEW EXACT PBP2A TEST, MODEL 891-000
K091766 · Binax, Inc. · Feb 2010
OXOID PBP2 1 LATEX AGGLUTINATION TEST
K011710 · Oxoid , Ltd. · Apr 2002
VELOGENE RAPID MRSA IDENTIFICATION ASSAY
K990640 · Id Biomedical Corp. · Jul 1999